Latest News

Hub.Tech SA's ( WSE:HUB ) earnings announcement last week didn't impress shareholders. While the headline numbers were...

Orsero S.p.A. ( BIT:ORS ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests...

It's been a mediocre week for Cantargia AB (publ) ( STO:CANTA ) shareholders, with the stock dropping 12% to kr3.17 in...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The board of Severn Trent PLC ( LON:SVT ) has announced that it will pay a dividend of £0.504 per share on the 12th of...

When close to half the companies in the Healthcare industry in Romania have price-to-sales ratios (or "P/S") below...

Shareholders of Formpipe Software AB (publ) ( STO:FPIP ) will be pleased this week, given that the stock price is up...

HIAG Immobilien Holding's (VTX:HIAG) stock is up by a considerable 12% over the past three months. As most would know...

TalkPool AG ( STO:TALK ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...

Alimentation Couche-Tard recently marked the grand opening of its 266,000-square-foot distribution center in Otsego, Minnesota, supporting nearly 500 Holiday and Circle K stores across the Twin Cities and Upper Midwest. This milestone accelerates the company’s multi-year effort to increase agility and efficiency throughout its North American supply chain, with two more distribution centers set to open soon. We'll explore how Couche-Tard’s new Minnesota distribution center could influence its...

Potential Brait PLC ( JSE:BAT ) shareholders may wish to note that the Non-Executive Director, Christoffel F. Wiese...

Sarepta Therapeutics (SRPT) announced major updates to the prescribing information for its gene therapy ELEVIDYS. These updates include a new boxed warning for acute serious liver injury risk and the removal of its non-ambulatory indication. See our latest analysis for Sarepta Therapeutics. Sarepta Therapeutics' latest prescribing changes for ELEVIDYS come amid a turbulent year, with heightened regulatory scrutiny piling onto already steep challenges. After a steep slide, Sarepta’s share...

On November 18, 2025, Glancy Prongay & Murray LLP announced that it had filed a class action lawsuit against Perrigo Company plc in the U.S. District Court for the Southern District of New York, alleging materially misleading statements and disclosure failures related to Perrigo's infant formula business acquired from Nestlé. This lawsuit raises significant concerns about historical underinvestment, manufacturing deficiencies, and the accuracy of prior financial reporting by Perrigo, which...

Key Insights The projected fair value for Tracsis is UK£4.98 based on 2 Stage Free Cash Flow to Equity Tracsis is...

Wondering if General Mills is a bargain right now? Let's dig into whether the stock's current price is as attractive as it seems. The stock climbed 1.9% over the past week, but is still down 23.9% year-to-date. This hints at shifting sentiment and possible opportunities ahead. Recent headlines have focused on General Mills' evolving product line and steady consumer demand as the company expands its health-conscious offerings and invests in key brands. These moves are shaping...

MGM Resorts International (MGM) just rolled out two big updates that could reshape its portfolio in Las Vegas. The company is investing $300 million in a major overhaul at MGM Grand. At the same time, it is introducing a fresh entertainment partnership at Bellagio’s Mayfair Supper Club. See our latest analysis for MGM Resorts International. Despite MGM’s high-profile revamp at MGM Grand and fresh entertainment push at Bellagio, the share price has yet to reflect renewed optimism. It is...

Mitsubishi HC Capital Inc. recently announced its half-year earnings for the period ended September 30, 2025, reporting sales of JPY 1.13 trillion and net income of JPY 88.79 billion, along with an increased interim dividend of JPY 22.00 per share payable December 5, 2025. The company also provided guidance for the fiscal year ending March 31, 2026, projecting net income of JPY 160 billion and earnings per share of JPY 111.44, reflecting management’s forward-looking expectations. We’ll now...

Ypsomed Holding (SWX:YPSN) released its half-year earnings, reporting net income of CHF 139 million compared to CHF 33 million a year earlier. Earnings per share also rose sharply in the same period. See our latest analysis for Ypsomed Holding. Ypsomed Holding’s robust jump in profits seems to have caught the market’s eye, with the share price gaining nearly 5% over the past month. However, longer-term momentum has faded, reflected in a 1-year total shareholder return of -7%. Still, investors...

Earlier this month, NICE Ltd. announced an expanded partnership with IGT Solutions to drive AI-powered customer experience transformation, while also introducing Arun Chandra as Chief Operating Officer to oversee the newly formed Global Customer Operations division. This period of corporate change came as NICE lifted its full-year revenue guidance and reported increased quarterly earnings, but also trimmed its future profitability forecast due to large-scale AI investments following a recent...

BGC Group recently reported third quarter results with revenue rising 31.2% year-on-year, although both revenue and EBITDA fell short of analyst forecasts. This earnings miss highlights the challenges companies can face in exceeding market expectations, even while delivering significant revenue growth. We'll examine how BGC Group's lower-than-expected earnings influence the company's investment narrative and analyst outlook. Rare earth metals are an input to most high-tech devices, military...

Wondering if Bayer's recent move in the markets makes it a true bargain, or just another value trap? You're not alone. Here is what really matters for investors looking for an edge. The stock has climbed 42.3% year-to-date and is up 40.0% over the last 12 months. However, it has taken a small dip of 2.9% this week, hinting at shifting moods around its growth potential and risk. Recent headlines have spotlighted Bayer's progress with new therapies and changes in its leadership team. Both...

BKV (BKV) has been in the spotlight after announcing third quarter earnings that surpassed expectations, along with revenue and net income growth. Investors are also paying close attention to strong production trends and strategic moves in its Power joint venture. See our latest analysis for BKV. After a string of upbeat earnings and the announcement of Power JV expansion, BKV’s 1-month share price return of nearly 28% has caught attention. This has pushed shares to a fresh high and...

In November 2025, net2phone, a segment of IDT Corporation, launched a HIPAA-compliant AI solution aimed at automating patient communications and simplifying administrative tasks for healthcare providers, with seamless integration into existing systems. This initiative highlights IDT’s push to modernize healthcare communications by offering secure, AI-powered tools that improve operational efficiency and patient satisfaction. We’ll explore how the launch of a healthcare-focused,...

Bilibili Inc. recently reported its third quarter results for the period ended September 30, 2025, highlighting a return to profitability with net income of CNY 470.23 million, along with the appointment of Ms. Lai Ying Tung as Joint Company Secretary in Hong Kong. One interesting insight is the company’s swing from a net loss previously to positive net income, reflecting material changes in operational performance. We'll explore how Bilibili's move to sustained profitability impacts its...